The Eureka Moment Behind a Scientific Discovery
We invest in key areas that will drive innovation within our pipeline for years to come.
We're focused on finding better ways to bring the right medicines to patients – tailoring and personalizing our therapies and letting the patient voice and experience guide us. We’re investing in key areas and technologies such as precision medicine, data convergence, genetics and genomics and patient-focused drug development.
We believe that innovation in these areas — along with our unique mix of therapeutic modalities and advanced tools — will drive innovation within our pipeline, advance programs with a stronger probability of success, and increase our potential to deliver better solutions to patients.
We’re integrating historically distinct areas of expertise and technology into a unified knowledge platform, improving how we collect, analyze and apply data to spark insights that can improve patients’ lives.
We’re using advanced technologies to help accelerate medicines and leveraging deep understanding of disease mechanisms to target the right patient with the right medicine at the right time.
Through one of the largest genomics research efforts in the world, our goal is to build a greater understanding of disease biology and human data to better inform critical decisions in the journey to create medicines.
From partnering with patients to advance drug development to diversifying our clinical trials to harnessing real-world data, our scientists use novel approaches that apply patient insights to deliver products and solutions for conditions with great unmet need.
We turn to our R&D toolbox — a mix of traditional and cutting-edge modalities — to create the best compound for a specific target. These modalities include gene and cell therapies, antibody-drug conjugates, targeted protein degraders and more.
From early experimental work to progressing late-stage programs, we use advanced technologies end-to-end across R&D, including artificial intelligence and machine learning, genetic medicine delivery, cell generation therapies and more.
Explore our career opportunities.
The AbbVie webpage you have requested is only intended for certain countries. (You will find the relevant information on the page.) Therefore, the website may contain information on medicinal products, other products or uses of these products that are not authorised in other countries or regions. If the latter applies to you, please contact your AbbVie national subsidiary to obtain the correct product information for your country. The AbbVie webpage you have requested is not in German. The AbbVie webpage you have requested may not be optimised for your screen size. Would you like to continue?